A detailed history of Stillwater Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stillwater Capital Advisors, LLC holds 1,094 shares of LLY stock, worth $870,112. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,094
Holding current value
$870,112
% of portfolio
0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $844,721 - $1.05 Million
1,094 New
1,094 $969,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $4,347 - $5,993
10 Added 0.91%
1,104 $592,000
Q3 2022

Oct 14, 2022

SELL
$296.48 - $337.87 $49,512 - $56,424
-167 Reduced 13.24%
1,094 $354,000
Q2 2022

Jul 13, 2022

BUY
$278.73 - $327.27 $130,724 - $153,489
469 Added 59.22%
1,261 $409,000
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $178,081 - $220,999
792 New
792 $219,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stillwater Capital Advisors, LLC Portfolio

Follow Stillwater Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stillwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stillwater Capital Advisors, LLC with notifications on news.